Earnings Alerts

Formosa Chemicals & Fibre (1326) Earnings Report: February Sales Reach NT$25.68B Despite 8.35% Drop

  • Formosa Chemicals reported February sales of NT$25.68 billion.
  • The company’s sales have experienced a decrease of 8.35%.
  • Currently, Formosa Chemicals has 1 buy rating, 10 hold ratings, and 3 sell ratings from market analysts.

A look at Formosa Chemicals & Fibre Smart Scores

FactorScoreMagnitude
Value5
Dividend2
Growth2
Resilience3
Momentum2
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Formosa Chemicals & Fibre Corporation, a company that produces and sells petrochemical products, nylon fiber, and rayon staple fiber, has received a positive outlook for its long-term performance according to the Smartkarma Smart Scores. These scores, which range from 1 to 5, indicate the overall outlook for the company based on different factors.

Formosa Chemicals & Fibre has received a score of 5 for value, indicating that the company is considered to be a good investment opportunity. However, its dividend score is only 2, suggesting that it may not be the best option for those seeking regular income. The company has also scored a 2 for growth, indicating that its potential for future growth may be limited. However, it has received a resilience score of 3, indicating that it is likely to withstand any potential challenges in the market. Lastly, its momentum score of 2 suggests that the company’s stock price may not be showing significant upward or downward movement at the moment.

Overall, Formosa Chemicals & Fibre Corporation has received a strong outlook for its long-term performance, with a high value score and a moderate resilience score. However, investors looking for regular dividends or significant growth may need to consider other options.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars